Rituximab versus fingolimod after natalizumab in multiple sclerosis patients. Alping P, Frisell T, Novakova L, Islam-Jakobsson P, Salzer J, Björck A, Axelsson M, Malmeström C, Fink K, Lycke J, et al. Ann Neurol. 2016 Mar 31. PMID: 27038238. Abstract CommentRecommendBookmarkWatch